Literature DB >> 24799337

Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity.

Meijuan Tu1, Liping Li1, Hongmei Lei1, Zhiyuan Ma1, Zhongjian Chen2, Siyuan Sun1, Siyun Xu1, Hui Zhou1, Su Zeng1, Huidi Jiang3.   

Abstract

Retrorsine (RTS) is a hepatotoxic pyrrolizidine alkaloid present in plants of the Senecio genus. The present study is aimed at clarifying the role of organic cation transporters (OCTs) in the liver disposition of RTS, and the coupling of OCT1 and cytochrome P450 (CYP) 3A4 in the hepatotoxicity of RTS. MDCK or LLC-PK1 cells stably expressing liver uptake or efflux transporters were used to investigate the interaction of RTS with these transporters. Primary cultured rat hepatocytes (PCRH) and double-transfected MDCK-hOCT1-CYP3A4 cells were used to determine the contribution of OCT1 and CYP3A4 to the toxicity of RTS. The results showed that RTS inhibited the OCT1-mediated 1-methyl-4-phenylpyridinium (MPP(+)) uptake in MDCK-hOCT1 cells with the IC50 of 2.25±0.30μM. The uptake of RTS in MDCK-hOCT1 cells and PCRH was significantly inhibited by OCT1 inhibitors, while hOCT3, human multidrug and toxin extrusion (hMATE) transporter 1, multidrug resistance 1 (MDR1), and breast cancer resistance protein (BCRP) showed weak or no obvious interaction with RTS. The toxic effect of RTS on the PCRH was attenuated by OCT1 inhibitors, quinidine and (+)-tetrahydropalmatine ((+)-THP). Compared to mock cells, MDCK-CYP3A4 cells showed a decrease in viability after being treated with RTS. Furthermore, RTS showed a more severe toxicity in the OCT1/CYP3A4 double-transfected cells compared to all other cells. Our data suggests that OCT1 mediates the liver-specific uptake of RTS, and plays an important role in RTS-induced hepatotoxicity together with CYP3A4. Consequently, the OCT1 inhibitors could be applied to protect the liver from the toxicity of RTS.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CYP3A4; Double-transfected cells; Hepatotoxicity; Organic cation transporter 1; Retrorsine; Transporters

Mesh:

Substances:

Year:  2014        PMID: 24799337     DOI: 10.1016/j.tox.2014.04.007

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  11 in total

Review 1.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

2.  Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy.

Authors:  Zhiyuan Ma; Shuanghui Lu; Dongli Sun; Mengru Bai; Ting Jiang; Nengming Lin; Hui Zhou; Su Zeng; Huidi Jiang
Journal:  Br J Pharmacol       Date:  2019-07-10       Impact factor: 8.739

Review 3.  Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.

Authors:  Bastian Haberkorn; Martin F Fromm; Jörg König
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

4.  Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.

Authors:  Tina Seitz; Robert Stalmann; Nawar Dalila; Jiayin Chen; Sherin Pojar; Joao N Dos Santos Pereira; Ralph Krätzner; Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  Genome Med       Date:  2015-06-18       Impact factor: 11.117

Review 5.  Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study.

Authors:  Cheng Zhang; Ning Wang; Yu Xu; Hor-Yue Tan; Sha Li; Yibin Feng
Journal:  Int J Mol Sci       Date:  2018-09-13       Impact factor: 5.923

6.  Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells.

Authors:  Anne-Margarethe Enge; Florian Kaltner; Christoph Gottschalk; Albert Braeuning; Stefanie Hessel-Pras
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 7.  The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.

Authors:  Frances Widjaja; Yasser Alhejji; Ivonne M C M Rietjens
Journal:  Planta Med       Date:  2021-11-05       Impact factor: 3.352

8.  Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.

Authors:  Zhangting Wang; Jiang Ma; Sheng Yao; Yisheng He; Kai-Kei Miu; Qingsu Xia; Peter P Fu; Yang Ye; Ge Lin
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

9.  Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.

Authors:  Suparmi Suparmi; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2020-06-09       Impact factor: 5.153

10.  Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells.

Authors:  Lukas Rutz; Lan Gao; Jan-Heiner Küpper; Dieter Schrenk
Journal:  Arch Toxicol       Date:  2020-09-10       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.